94386 ⎘
Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems Benzopyrazoles; Hydrogenated benzopyrazoles
INHIBITORS OF NLRP3 INFLAMMASOME
#2HETEROARYL COMPOUNDS AS MULTI-TARGET PROTEIN KINASE INHIBITORS
#3C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#4NOVEL COMPOUNDS AS CK2 INHIBITORS
#5NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF
#6SULFONYL DERIVATIVES AS CCR6 INHIBITORS
#7SALT-INDUCIBLE KINASE INHIBITOR COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME
#8COMPOUND CONTAINING BENZENE RING AND APPLICATION THEREOF
#9HETEROCYCLIC INHIBITORS OF MCT4
#10INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER
#11ATM KINASE INHIBITORS
#12COMPOSITIONS AND METHODS FOR TREATING CANCER
#13MODULATORS OF FSHR AND USES THEREOF
#14INDAZOLE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS
#15AMBIPOLAR MOLECULE, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF
#16MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO
#17BICYCLIC CARBOXAMIDES AND METHODS OF USE THEREOF
#18Compounds
#19COMPOUNDS AND METHODS FOR INHIBITING FASCIN
#20PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS
#21SOLID FORMS OF HETEROCYCLYLAMIDES AS IRAK4 INHIBITORS
#22Nitrogen-Containing Heterocyclic Compounds
#23HSD17B13 INHIBITORS AND USES THEREOF
#24SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF
#25INHIBITORS OF NLRP3 INFLAMMASOME
#26OLIGO-BENZAMIDE ANALOGS AND THEIR USE IN CANCER TREATMENT
#27NOVEL AMINO ACID DERIVATIVES
#28NOVEL BENZENE DERIVATIVE AND IMMUNOSUPPRESSION-RELATED USE THEREOF
#29MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND METHODS
#30TRIFLUOROMETHANESULFONYLATING AGENT COMPOSITION AND METHOD FOR PRODUCING TRIFLUOROMETHANESULFONYLOXY COMPOUND OR TRIFLUOROMETHANESULFONYL COMPOUND
#31COMPOUNDS USEFUL FOR REDUCING URIC ACID
#32BICYCLE COMPOUNDS AS TEAD INHIBITOR
#33CORONAVIRUS MAIN PROTEASE INHIBITORS AND METHODS USING SAME
#34AGENT FOR REDUCING VISCERAL FAT WEIGHT
#35ALKYLAMINE OR HETEROALKYLAMINE DERIVATIVES AS INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF
#36WORKFLOW FOR GENERATING COMPOUNDS WITH BIOLOGICAL ACTIVITY AGAINST A SPECIFIC BIOLOGICAL TARGET
#37ESTROGEN RECEPTOR BETA LIGANDS FOR THE PREVENTION AND TREATMENT OF MULTIPLE SCLEROSIS (MS) AND OTHER DEMYELINATING, INFLAMMATORY AND NEURODEGENERATIVE DISEASES
#38QUATERNARY INDAZOLE GLUCOCORTICOID RECEPTOR ANTAGONISTS
#39Compounds
#40INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE
#41TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
#42SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS
#43NOVEL HETEROCYCLIC INHIBITOR FOR HISTONE DEACETYLASE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#44ORAL COMPLEMENT FACTOR D INHIBITORS
#45ACRYLAMIDE COMPOUNDS
#46CARBOXAMIDE COMPOUNDS AS PGE2 RECEPTOR ANTAGONISTS
#47RAFT AGENT FOR PHOTO-CONTROLLED POLYMERIZATION, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF
#48COMPOUNDS
#49MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO
#50NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS
#51MODULATORS OF THE INTEGRATED STRESS PATHWAY
#52BIFUNCTIONAL ARYLSULPHONAMIDE COMPOUNDS
#53SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONS
#54METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS
#55COMPOUNDS AND METHODS OF ACTIVATING LIPOPROTEIN LIPASE
#56THERAPEUTIC COMPOUNDS AND METHODS OF USE
#57HETEROCYCLIC AMIDES AND METHODS OF USING THE SAME
#58INDAZOLE COMPOUND AND PHARMACEUTICAL
#59C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#60COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES
#61PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS
#62NOVEL CAPSID ASSEMBLY INHIBITORS
#63MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO
#64SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS
#65COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
#66HETEROCYCLIC ALDEHYDE TRAPPING COMPOUNDS AND USES THEREOF
#672-SUBSTITUTED BICYCLO[1.1.1]PENTANES
#68SUBSTITUTED INDAZOLE PROPIONIC ACID DERIVATIVE COMPOUNDS AND USES THEREOF
#69Covalent Inhibitors As Antiviral Agents
#70AGENT FOR REDUCING VISCERAL FAT WEIGHT
#71ARGININE METHYLTRANSFERASE INHIBITOR AND USE THEREOF
#72ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#73PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF
#74ETHACRYNIC ACID DERIVATIVES AS INHIBITORS OF MPRO PROTEASE AND SARS-COV-2 REPLICATION
#75BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
#76XANTHINE OXIDASE INHIBITOR
#77MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS
#78Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
#79INDANONE AND TETRALONEKETO OR HYDROXYL OXIMES AS CANCEL THERAPEUTICS
#80GPX4 INHIBITORS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING GPX4-MEDIATED DISEASES
#81BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5
#82NOVEL METHOD FOR PREPARING SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST
#83METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST
#84METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST
#85INHIBITORS OF KINASE NETWORKS AND USES THEREOF
#86Inhibitors of receptor interacting protein kinase I for the treatment of disease
#87Inhibitors of Rho Associated Coiled-Coil Containing Protein Kinase
#88TOLL-LIKE RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USE
#89SUBSTITUTED CYCLIC MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME
#90MODULATORS OF THE INTEGRATED STRESS PATHWAY
#91ARYLTHIOETHER ACETAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
#92TEAD inhibitors and methods of uses thereof
#93SULFAMOYL BENZENE DERIVATIVES AND USES THEREOF
#94BET SUBFAMILY INHIBITORS AND METHODS USING SAME
#952-SUBSTITUTED BICYCLO[1.1.1]PENTANES
#96HSD17B13 INHIBITORS AND/OR DEGRADERS
#97Quaternary indazole glucocorticoid receptor antagonists
#98Bicyclic carboxamides and methods of use thereof
#99CARBOXYLIC ACID, ACYL SULFONAMIDE AND ACYL SULFAMIDE-DERIVATIZED BICYCLIC AZA-HETEROAROMATICS AS SELECTIVE MCL-1 INHIBITORS AND AS DUAL MCL-1/BCL-2 INHIBITORS
#100INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS LIPOAMIDE DEHYDROGENASE
#101COMPOUNDS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE, DEGENERATIVE AND METABOLIC DISORDERS
#102Compounds and methods for inhibiting fascin
#103INDAZOLE AND PYRAZOLOPYRIDINE COMPOUNDS AS INHIBITORS OF NLRP3 INFLAMMASOME
#104RATIONAL DESIGN, OPTIMIZATION, AND BIOLOGICAL EVALUATION OF NOVEL MEK4 INHIBITORS AGAINST PANCREATIC ADENOCARCINOMA
#105HISTONE DEACETYLASE INHIBITORS
#106Methods and intermediates for preparing therapeutic compounds
#107ARYL ETHER COMPOUNDS AS TEAD MODULATORS
#108HSD17B13 INHIBITORS AND USES THEREOF
#109SULFONAMIDE DERIVATIVES FOR PROTEIN DEGRADATION
#110Development of material for hole blocking layer with high efficiency and long lifespan, and organic light-emitting device and electronic apparatus utilizing the same
#111NOVEL COMPOUNDS
#112Inhibitors of NLRP3 inflammasome
#113NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS
#114INHIBITORS OF NLRP3 INFLAMMASOME
#115INHIBITORS OF NLRP3 INFLAMMASOME
#116INHIBITORS OF PU.1 FOR THE TREATMENT OF DISEASE
#117HSD17B13 INHIBITORS AND USES THEREOF
#118IMIDAZOQUINOLINE OR BENZOINDAZOLONE COMPOUND AND INTERMEDIATE FOR PREPARING SAME
#119Processes of making 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
#120COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH LPA RECEPTOR ACTIVITY
#121HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR FORMING ORGANIC LAYER
#122BICYCLIC COMPOUNDS, COMPOSITIONS AND USE THEREOF
#123CSF1R KINASE INHIBITOR AND USE THEREOF
#124MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#125INHIBITORS OF NLRP3 INFLAMMASOME
#126Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases
#127SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS
#128NAMPT MODULATORS
#129INDAZOLE DERIVATIVES AS CANNABINOID RECEPTOR PARTIAL AGONISTS
#130NANOMATERIALS COMPRISING ESTER-LINKED ACETALS
#131COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
#132HETEROCYCLIC COMPOUND
#133AGENT FOR REDUCING VISCERAL FAT WEIGHT
#134Carbamate compounds and methods of making and using same
#135NOVEL COMPOUNDS
#136Modulators of mas-related G-protein receptor X2 and related products and methods
#137INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF
#138PROCESSES FOR PREPARING MODULATORS OF ALPHA-1 ANTITRYPSIN
#139Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptor
#140SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION
#141METHIONINE METABOLIC PATHWAY INHIBITORS
#142PREPARATION METHOD FOR FUSED PYRAZOLE-TYPE COMPOUND
#143Substituted Heterocyclyl Derivatives as CDK Inhibitors
#144a-CARBONYL ALKENYL ESTER PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#145Heterocyclic compound
#146SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA
#147SULFONE DERIVATIVES
#148BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF
#149Substituted Alkynylene Compounds As Anticancer Agents
#150Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD
#151Pyrazolo compounds and methods of use thereof
#152Indazole Derivatives
#153COMPOUND CONTAINING BENZENE RING AND APPLICATION THEREOF
#154Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
#155COMPOUND AS A UBR BOX DOMAIN LIGAND
#156COMPOUND AS A UBR BOX DOMAIN LIGAND
#157AFMT ANALOGS AND THEIR USE IN METHODS OF TREATING PARKINSON'S DISEASE
#158BENZOPYRAZOLE COMPOUND
#159Inhibitors of HIF-2α and methods of use thereof
#160Methods and Compositions for Targeting Tregs using CCR8 Inhibitors
#161SELECTIVE NON-CYCLIC NUCLEOTIDE ACTIVATORS FOR THE CAMP SENSOR EPAC1
#162C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#163RORgT INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF
#164LIGHT EMITTING ELEMENT
#165Small molecule inhibitors of TEAD transcription factors
#166TRNA SYNTHETASE INHIBITORS
#167UREA COMPOUND FOR ANTAGONIZING LPA1 RECEPTOR
#168INDAZOLE HYDRAZIDE COMPOUND AND APPLICATION THEREOF
#169POLYAROMATIC UREA DERIVATIVES AND THEIR USE IN THE TREATMENT OF MUSCLE DISEASES
#170Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptor
#171NUCLEAR RECEPTOR MODULATORS
#172INDAZOLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF HERPES VIRUSES
#173CONJUGATES OF-ELECTRON-PAIR-DONATING HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS
#174Bicyclic compounds
#175γ-diketones as Wnt/β-catenin signaling pathway activators
#176Inhibitors of NLRP3 inflammasome
#177Methods and compounds for restoring mutant p53 function
#178Bicyclic carboxamides and methods of use thereof
#179Carboxylic acid aromatic amides
#180SMALL MOLECULE MODULATORS OF SIGMA-1 AND SIGMA-2 RECEPTORS AND USES THEREOF
#181Quaternary indazole glucocorticoid receptor antagonists
#182INHIBITORS OF HIF-2ALPHA
#183Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
#184AGENT FOR REDUCING VISCERAL FAT WEIGHT
#185Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
#186NOVEL HEADGROUP LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#187Novel compounds and their use in therapy
#188NOVEL HYDRAZONE DERIVATIVE IN WHICH TERMINAL AMINE GROUP IS SUBSTITUTED WITH ARYL GROUP OR HETEROARYL GROUP, AND USE THEREOF
#189COMPOUNDS
#190Heterocyclic compound
#191(AZA)INDAZOLYL-ARYL SULFONAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
#192SOLID STATE FORMS OF ARRY-797 AND PROCESS FOR PREPARATION THEREOF
#193COMPOUNDS FOR TREATING PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) MEDIATED DISEASES OR CONDITIONS
#194Adaptive sheet caliper control system and apparatus and methods
#195MODULATORS OF THE INTEGRATED STRESS PATHWAY
#196Processes of making 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
#197ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#198Modulators of Mas-related G-protein receptor X2 and related products and methods
#199SMARCA INHIBITORS AND USES THEREOF
#200Inhibitors of NLRP3 inflammasome
#201Aromatic sulfonamide derivatives
#202PROSTAGLANDIN E2 RECEPTOR 4 ANTAGONISTS AND USES THEREOF
#203BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
#204AROMATIC VINYL OR AROMATIC ETHYL DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION
#205Toll-like receptor antagonist compounds and methods of use
#206INDAZOLE COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS
#207Organic electroluminescent element and electronic device
#208COMPOUNDS CONTAINING A SULFONIC GROUP AS KAT INHIBITORS
#209HETEROCYCLIC INHIBITORS OF MCT4
#210TERTIARY AMINE DERIVATIVES AND THEIR USES FOR TREATING A VIRAL INFECTION
#211Synthesis method for 1-methyl-1H-indazole-6-carboxylic acid
#212COMPOUND AS IRAK INHIBITOR
#213Novel compounds and methods of use treating fructose-related disorders or diseases
#214INHIBITORS OF SARM1
#215PROCESS FOR PREPARATION OF AXITINIB
#216INHIBITORS OF CD40-CD154 BINDING
#217DIRECT AROMATIC CARBON-OXYGEN AND CARBON-HYDROGEN BOND FUNCTIONALIZATION VIA ORGANIC PHOTOREDOX CATALYST
#218SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS
#219Therapeutic indazoles
#220HYDRAZIDE COMPOUND AND KINASE INHIBITOR
#221BIARYL DERIVATIVE AS GPR120 AGONIST
#222INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER
#223SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION
#224Compositions and methods for the treatment of cancer
#225COMPOUNDS FOR TREATING RESPIRATORY DISEASE
#226Substituted Heterocyclyl Derivatives as CDK Inhibitors
#227Inhibitors of dihydroceramide desaturase for treating disease
#228PREPARATION AND APPLICATION OF CLASS OF N-CONTAINING HETEROCYCLIC COMPOUNDS HAVING IMMUNOREGULATORY FUNCTION
#229BENZO-AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS
#230Heterocyclic compound
#231Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
#232Oligo-benzamide analogs and their use in cancer treatment
#233Methods and intermediates for preparing therapeutic compounds
#234DUAL ACTING FKBP12 AND FKBP52 INHIBITORS
#235Bicyclic compounds and their use in the treatment of cancer
#236Substituted alkynylene compounds as anticancer agents
#237Inhibitors of kinase networks and uses thereof
#238Benzopyrazole compound used as RHO kinase inhibitor
#239Diacylglyceride O-acyltransferase 2 inhibitors
#240Activator of TREK (TWIK RElated Kchannels) channels
#241Compounds and methods for inhibiting fascin
#242Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
#243FUSED DIHYDRO-4H-PYRAZOLO[5,1-C][1,4]OXAZINYL COMPOUNDS AND ANALOGS FOR TREATING CNS DISORDERS
#244PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS
#245COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATMENT OF DISEASES INVOLVING ACIDIC OR HYPOXIC DISEASED TISSUES
#246Development of material for hole blocking layer with high efficiency and long lifespan, and organic light-emitting device and electronic apparatus utilizing the same
#247SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION
#248Heterocyclic amide compounds having an RORvt inhibitory action
#249Compounds and uses thereof for the modulation of hemoglobin
#250Indole compounds and analogues thereof
#251ACYLSUFONAMIDE COMPOUNDS USEFUL AS EP3 RECEPTOR ANTAGONISTS
#252SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF
#253Selective androgen receptor degrader (SARD) ligands and methods of use thereof
#254Indomethacin analogs for the treatment of castrate-resistant prostate cancer
#255ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF
#256Anti-fibrotic compounds
#257MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7 INHIBITORS
#258Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
#259Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases
#260COMPOUNDS ACTING AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE
#261ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE
#262Compounds and Methods for Treating Bacterial Infections
#263NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN
#264AGENT FOR REDUCING VISCERAL FAT WEIGHT
#265Carbamate compounds and methods of making and using same
#266COMPOUNDS AND METHODS FOR HEMATOPOIETIC REGENERATION
#267Heterocyclic compound
#268PRIMARY CARBOXAMIDES AS BTK INHIBITORS
#269Small molecule inhibitors of Ebola and Lassa fever viruses and methods of use
#270Inhibitors of Rho associated coiled-coil containing protein kinase
#271METHOD FOR PREPARING A POLYFLUORINATED COMPOUND
#272COMPOSITIONS AND METHODS FOR TREATING CANCER
#273Opioid receptor modulators and products and methods related thereto
#274COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN
#275Analogs of fexaramine and methods of making and using
#276OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO
#277MODULATORS OF CELLULAR ADHESION
#278Compounds for treatment of cardiac arrhythmias and heart failure
#279Compositions for the treatment of pulmonary fibrosis
#280NUCLEAR RECEPTOR MODULATORS
#281Phenylamine compounds
#282C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#283Small-Molecule HIV-1 Capsid Protein Inhibitors and Methods Using Same
#284Preparation of pyrazolo[3,4-B]pyridines as antimalarials
#285Bicyclic heterocycles as FGFR inhibitors
#286Inhibitors of receptor interacting protein kinase I for the treatment of disease
#287PRODRUGS OF THE TYROSINE KINASE INHIBITOR FOR TREATING CANCER
#288Pesticidal compounds
#289P300/CBP hat inhibitors
#290Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application
#291Workflow for generating compounds with biological activity against a specific biological target
#292TRNA synthetase inhibitors
#293Heterocyclic compounds as pesticides
#294E3 UBIQUITIN LIGASE AGONISTS, PHARMACEUTICAL COMPOSITIONS INCLUDING THE E3 UBIQUITIN LIGASE AGONISTS, RELATED METHODS OF USE
#295Compounds and pharmaceutical compositions for modulating SGK activity, and methods thereof
#296Bicyclic carboxamides and methods of use thereof
#297BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE
#298Heterocyclic compounds as pesticides
#299Sulfonyldiazoles and N-(fluorosulfonyl)azoles, and methods of making the same
#300Bicyclic compounds and their use in the treatment of cancer